SOLV Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Based on the data provided, Solventum Corp (SOLV) does not present a strong buy opportunity for a beginner investor with a long-term strategy and $50,000-$100,000 available for investment. While there are some positive aspects, such as improved net income and EPS growth in the latest quarter, the lack of strong trading signals, mixed analyst ratings, and the absence of significant positive catalysts suggest that holding off on buying this stock is the better choice at this time.
The MACD is positive and expanding, indicating bullish momentum. However, the RSI is in the neutral zone at 72.878, and moving averages are converging, showing no clear trend. The stock is trading near its resistance level (R1: 69.183), which could limit immediate upside potential.
Analysts like KeyBanc and Mizuho have upgraded the stock recently, citing positive long-term growth potential.
Revenue declined by 3.71% YoY in Q4 2025, and gross margin dropped by 4.69%. Analyst ratings are mixed, with some firms expressing concerns about the company's ability to accelerate growth in competitive markets. Additionally, there is no recent congress trading data or significant insider/hedge fund activity to support confidence in the stock.
In Q4 2025, Solventum's revenue dropped to $1.998 billion (-3.71% YoY), but net income increased to $63 million (+103.23% YoY), and EPS rose to $0.36 (+100% YoY). Gross margin declined to 51.4% (-4.69% YoY), indicating some operational challenges despite profitability improvements.
Analyst ratings are mixed. Recent upgrades from KeyBanc and Mizuho highlight long-term growth potential, but firms like Rothschild & Co have initiated coverage with a Sell rating, citing challenges in accelerating organic growth and competitive market pressures. Price targets range from $60 to $100, reflecting uncertainty about the stock's near-term performance.
